Baird Upgrades Acorda Therapeutics (ACOR) to Outperform; Significant Opportunity - StreetInsider.com (subscription) PDF Print
StreetInsider.com (subscription)We anticipate exclusion of patients with known seizure risk and moderate/severe renal impairment, but not something more onerous such as restrictive

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.